Diphenylcyclopropenone (DCP) Local Therapy in the Progression of cutaneous Melanoma Metastases with Nivolumab Therapy leads to a lasting Complete Remission

被引：0
|
作者：
Amschler, K. [1 ]
Cevik, N. [1 ]
Vlahova, L. [1 ]
Brunnert, F. [1 ]
Hoffmann, J. [1 ]
Cihan, Y. [1 ]
Schoen, M. P. [1 ]
Thoms, K. M. [1 ]
机构：
[1] Univ Med Gottingen, Gottingen, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2020年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P106
引用
收藏
页码：72 / 72
页数：1
相关论文
共 50 条
  • [41] Disease Progression and Death From Cervical Melanoma in a Patient Undergoing Nivolumab Therapy: A Case Report
    Macedo, Mateus Lopes
    da Costa, Rafael Everton Assuncao Ribeiro
    dos Reis, Cristiane Amaral
    Da Silva Junior, Raimundo Geronimo
    Pires, Ary Oliveira
    Vieira, Sabas Carlos
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)
  • [42] Adjuvant radiation therapy for high-risk nodal metastases from cutaneous melanoma
    Guadagnolo, B. Ashleigh
    Zagars, Gunar K.
    LANCET ONCOLOGY, 2009, 10 (04): : 409 - 416
  • [43] Personalized Treatment Selection Leads to Low Rates of Local Salvage Therapy for Bone Metastases
    Mathis, Noah J.
    Doyle, Connor J.
    Rosen, Daniel B.
    Wijetunga, N. Ari
    Vaynrub, Max
    Bartelstein, Meredith
    Guttmann, David M.
    Brennan, Victoria S.
    Yamada, Yoshiya J.
    Gillespie, Erin F.
    Yerramilli, Divya
    Yang, Jonathan T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 112 (01): : 99 - 105
  • [44] Personalized Treatment Selection Leads to Low Rates of Local Salvage Therapy for Bone Metastases
    Mathis, Noah J.
    Doyle, Connor J.
    Rosen, Daniel B.
    Wijetunga, N. Ari
    Vaynrub, Max
    Bartelstein, Meredith
    Guttmann, David M.
    Brennan, Victoria S.
    Yamada, Yoshiya J.
    Gillespie, Erin F.
    Yerramilli, Divya
    Yang, Jonathan T.
    International Journal of Radiation Oncology Biology Physics, 2022, 112 (01): : 99 - 105
  • [45] Biweekly gemcitabine therapy induces complete remission in cutaneous angiosarcoma resistant to multiple anticancer drugs
    Kajihara, Ikko
    Maeda, Saki
    Yamada, Saori
    Izumi, Kanako
    Masuguchi, Shinichi
    Fukushima, Satoshi
    Jinnin, Masatoshi
    Ihn, Hironobu
    JOURNAL OF DERMATOLOGY, 2015, 42 (12): : 1197 - 1198
  • [46] A case of cabozantinib therapy leading to complete remission for massive intra-intestinal bleeding and worsening metastatic sites following nivolumab and ipilimumab therapy
    Ishida, Kyohei
    Hasegawa, Go
    Ikeda, Yohei
    Hara, Noboru
    Nishiyama, Tsutomu
    UROLOGY CASE REPORTS, 2023, 51
  • [47] Chemosensitivity of malignant melanoma models: Longterm complete remission after regional hyaluronidase/vinblastine therapy
    Spruss, T
    Bernhardt, G
    IMMUNODEFICIENT ANIMALS: MODELS FOR CANCER RESEARCH, 1996, 51 : 145 - 150
  • [48] Should Targeted Therapy Be Continued in BRAF-Mutant Melanoma Patients after Complete Remission?
    Bedouelle, Eve
    Nguyen, Jean Michel
    Varey, Emilie
    Khammari, Amir
    Dreno, Brigitte
    DERMATOLOGY, 2022, 238 (03) : 517 - 526
  • [49] Complete Remission of Malignant Melanoma under Therapy with a BRAF-Inhibitor - What happened next?
    Tolk, H.
    Satzger, I.
    Mohr, P.
    Zimmer, L.
    Weide, B.
    Kapp, A.
    Gutzmer, R.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2014, 12 : 14 - 14
  • [50] Complete Remission of metastatic Melanoma under Therapy with Trametinib after Treatment Failure of Immunotherapy with Pembrolizumab
    Wahl, R.
    Ruebben, A.
    Amir, Y.
    Cacchi, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 70 - 70
12345